Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Prostatic Neoplasms 3 Urinary Bladder Neoplasms 1 Prostate Cancer Cured 1 Neoplasms 1 Kidney Neoplasms 1 Frailty 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1

Interventions

pembrolizumab 28 Docetaxel 21 Gemcitabine 19 Nivolumab 15 Paclitaxel 13 Prednisone 12 Leuprolide 11 pazopanib 10 Radiotherapy 10 Cisplatin 10 Sunitinib 9 Sorafenib 9 Ipilimumab 8 Blood Specimen Collection 8 Bevacizumab 8 avelumab 7 atezolizumab 7 Therapeutics 7 Thalidomide 7 Cyclophosphamide 7 Carboplatin 7 Standard of Care 6 Radiation 6 Mitomycin 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 padeliporfin 5 enzalutamide 5 cemiplimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Geriatric Assessment × Genitourinary × Clear all

NCT01776138 2021-10-06

PORCH

UNC Lineberger Comprehensive Cancer Center

Urinary Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡